AUSTAR Sets 25 August Board Meeting to Approve 1H 2026 Interim Results and Assess Dividend

Bulletin Express08-13

The board of Austar Lifesciences Limited will convene on 25 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The agenda also includes consideration of an interim dividend declaration.

The meeting date was disclosed in an announcement released on 13 August 2026. As of that date, Austar’s Board consists of four executive directors (Ho Kwok Keung Mars, Ho Kin Hung, Zhou Ning and Bian Ce), one non-executive director (Ji Lingling) and three independent non-executive directors (Cheung Lap Kei, Chiu Hoi Shan and Leung Oi Kin).

Chairman and Chief Executive Officer Ho Kwok Keung Mars signed the notice on behalf of the Board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment